These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23261527)

  • 1. Emerging targets in lipid-based therapy.
    Tucker SC; Honn KV
    Biochem Pharmacol; 2013 Mar; 85(5):673-688. PubMed ID: 23261527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid droplets in inflammation and cancer.
    Bozza PT; Viola JP
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):243-50. PubMed ID: 20206487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive lipid metabolism in platelet "first responder" and cancer biology.
    Kanikarla-Marie P; Kopetz S; Hawk ET; Millward SW; Sood AK; Gresele P; Overman M; Honn K; Menter DG
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):439-454. PubMed ID: 30112590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging targets in lipid metabolism for cancer therapy.
    Terry AR; Hay N
    Trends Pharmacol Sci; 2024 Jun; 45(6):537-551. PubMed ID: 38762377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting lipid mediators in cancer biology.
    Sulciner ML; Gartung A; Gilligan MM; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):557-572. PubMed ID: 30136088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of inflammation in cancer by eicosanoids.
    Greene ER; Huang S; Serhan CN; Panigrahy D
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):27-36. PubMed ID: 21864702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.
    Butler LM; Perone Y; Dehairs J; Lupien LE; de Laat V; Talebi A; Loda M; Kinlaw WB; Swinnen JV
    Adv Drug Deliv Rev; 2020; 159():245-293. PubMed ID: 32711004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Understanding of Bioactive Lipids in Neuro-Immune Interactions: Lessons from an Animal Model of Multiple Sclerosis.
    Kihara Y
    Adv Exp Med Biol; 2019; 1161():133-148. PubMed ID: 31562628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis: a redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins.
    Gutierrez LL; Maslinkiewicz A; Curi R; de Bittencourt PI
    Biochem Pharmacol; 2008 Jun; 75(12):2245-62. PubMed ID: 18440492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Inflammation in Hypertension: Targeting Lipid Mediators Unbalance and Nitrosative Stress.
    Bruno AS; Lopes PDD; de Oliveira KCM; de Oliveira AK; de Assis Cau SB
    Curr Hypertens Rev; 2021; 17(1):35-46. PubMed ID: 31858899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2.
    Salvado MD; Alfranca A; Haeggström JZ; Redondo JM
    Trends Mol Med; 2012 Apr; 18(4):233-43. PubMed ID: 22425675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of Protein Lipidation.
    Ganesan L; Levental I
    J Membr Biol; 2015 Dec; 248(6):929-41. PubMed ID: 26280397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cell proliferation and apoptosis by bioactive lipid mediators.
    Clària J
    Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):369-82. PubMed ID: 18221047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid mediators of inflammation in rheumatoid arthritis and osteoarthritis.
    Brouwers H; von Hegedus J; Toes R; Kloppenburg M; Ioan-Facsinay A
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):741-55. PubMed ID: 27107510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.
    Shimizu T
    Annu Rev Pharmacol Toxicol; 2009; 49():123-50. PubMed ID: 18834304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition.
    Ooi KM; Vacy K; Boon WC
    Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: Druggable Lipid Signaling Pathways.
    Kihara Y
    Adv Exp Med Biol; 2020; 1274():1-4. PubMed ID: 32894504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated administration of the NSAID meloxicam alters the plasma and urine lipidome.
    Rivera-Velez SM; Broughton-Neiswanger LE; Suarez M; Piñeyro P; Navas J; Chen S; Hwang J; Villarino NF
    Sci Rep; 2019 Mar; 9(1):4303. PubMed ID: 30867479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.